# Advisor Review - Advisor 1/3

**Role:** Academic advisor checking for fatal errors
**Model:** gpt-5.2-2025-12-11
**Paper:** paper.pdf
**Reasoning effort:** high
**Timestamp:** 2026-01-29T14:23:12.945025
**Response ID:** resp_0873c35a4640609f00697b5e4c24f8819f85fa2f4a1a91cea8
**Tokens:** 17823 in / 4865 out
**Response SHA256:** c392439e790aa157

---

I checked the draft for **fatal** problems in the four categories you listed (data-design alignment, regression sanity, completeness, and internal consistency). Based on what’s in the draft excerpt you provided (Tables 1–2; Figures 1–15 as referenced; no regression tables shown), I do **not** see a data/design impossibility, broken results, placeholders, or a hard contradiction that would embarrass you at a journal.

Key checks that *do* pass (i.e., no fatal issue found):
- **Treatment timing vs. data coverage:** All policy dates used for empirical patterns involving THC are within the **2018–2019** window where you state THC name-matching is reliable; your crash data cover **through 2019**, so you are not claiming effects in years you don’t observe.
- **RDD “both sides” requirement:** The border maps/plots you highlight for THC discontinuities are explicitly **legal vs. illegal** border comparisons in **2018–2019**, so (as described) they have observations on both sides of the cutoff.
- **DiD claims vs. data availability:** You correctly acknowledge the **2006–2015 gap** prevents event studies / adoption-window dynamics; you do not present an event-study result that would be impossible with your coverage.
- **Completeness:** No “TBD/TODO/XXX/NA” placeholders appear in the tables/figures shown; figures and tables referenced in the excerpt appear to exist; N’s are provided where you summarize sample sizes.
- **Internal numeric consistency:** The crash totals in Table 2 sum to ~70k, consistent with the abstract; the 2018–2019 THC percentages shown in Figure 2 are consistent with the pooled rates in Table 2 Panel C.

ADVISOR VERDICT: PASS